Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | LAP3 | P28838 | 3/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leu-Leu SCHEMBL235249 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL11140120 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL29401942 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL18774992 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL235250 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL13737576 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL30771444 | 0.98 | ALDH1A1 (0.58) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| Leu-Leu SCHEMBL29400696 | 0.98 | ALDH1A1 (0.58) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| SCHEMBL2722888 | 0.96 | ALDH1A1 (0.56) | ALDH1A1MAPTSLC7A5MEN1LMNA | |
| SCHEMBL1019805 | 0.96 | ALDH1A1 (0.56) | ALDH1A1MAPTSLC7A5MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119224161-A | Method for detecting various dipeptides in rumen fluid of ruminant | 中国科学院亚热带农业生态研究所 | 2024-12-31 | — | — | CN | claimed |
| EP-0460065-B1 | A PROCESS FOR THE GENERATION OF PROLIFERATING CD4 LYMPHOCYTES | TERUMO CORP (JP) | 1994-08-31 | — | — | EP | claimed |
| US-20060083685-A1 | Opioid metallopeptide compositions and methods | PALATIN TECHNOLOGIES, INC. (US) | 2006-04-20 | — | — | US | disclosed |
| US-6979436-B2 | Opioid metallopeptide compositions and methods | PALATIN TECHNOLOGIES, INC. (US) | 2005-12-27 | — | — | US | disclosed |
| US-20050181447-A1 | OPIOID METALLOPEPTIDE COMPOSITIONS AND METHODS | PALATIN TECHNOLOGIES, INC. | 2005-08-18 | — | — | US | disclosed |
| WO-2001036006-A1 | OPIOID METALLOPEPTIDE COMPOSITIONS AND METHODS | PALATIN TECHNOLOGIES, INC. (US) | 2001-05-25 | — | — | WO | disclosed |
| US-5919897-A | NOVEL OPIOID PEPTIDES | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1999-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050181447-A1 | OPIOID METALLOPEPTIDE COMPOSITIONS AND METHODS | OPRM1, OPRL1, OPRK1 | ALDH1A1 3643/4885MAPT 1397/4885SLC7A5 2036/4885 |
| US-20060083685-A1 | Opioid metallopeptide compositions and methods | OPRM1, OPRL1, OPRK1 | ALDH1A1 3635/4885MAPT 1451/4885SLC7A5 2103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.